Letter to the Editor
Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
Read
9681
Timeswas read the article
2564
Total PDF
7117
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 21 | 8 | 29 |
| 2025 5 | 113 | 42 | 155 |
| 2025 4 | 68 | 43 | 111 |
| 2025 3 | 77 | 39 | 116 |
| 2025 2 | 68 | 30 | 98 |
| 2025 1 | 43 | 41 | 84 |
| 2024 12 | 43 | 30 | 73 |
| 2024 11 | 76 | 37 | 113 |
| 2024 10 | 63 | 24 | 87 |
| 2024 9 | 58 | 25 | 83 |
| 2024 8 | 68 | 41 | 109 |
| 2024 7 | 63 | 34 | 97 |
| 2024 6 | 58 | 22 | 80 |
| 2024 5 | 55 | 44 | 99 |
| 2024 4 | 78 | 32 | 110 |
| 2024 3 | 74 | 24 | 98 |
| 2024 2 | 53 | 29 | 82 |
| 2024 1 | 56 | 29 | 85 |
| 2023 12 | 39 | 43 | 82 |
| 2023 11 | 64 | 54 | 118 |
| 2023 10 | 41 | 37 | 78 |
| 2023 9 | 37 | 32 | 69 |
| 2023 8 | 47 | 22 | 69 |
| 2023 7 | 46 | 28 | 74 |
| 2023 6 | 43 | 19 | 62 |
| 2023 5 | 70 | 36 | 106 |
| 2023 4 | 40 | 20 | 60 |
| 2023 3 | 72 | 32 | 104 |
| 2023 2 | 64 | 24 | 88 |
| 2023 1 | 48 | 31 | 79 |
| 2022 12 | 401 | 39 | 440 |
| 2022 11 | 78 | 36 | 114 |
| 2022 10 | 84 | 41 | 125 |
| 2022 9 | 96 | 40 | 136 |
| 2022 8 | 64 | 45 | 109 |
| 2022 7 | 78 | 56 | 134 |
| 2022 6 | 60 | 39 | 99 |
| 2022 5 | 81 | 56 | 137 |
| 2022 4 | 65 | 43 | 108 |
| 2022 3 | 95 | 54 | 149 |
| 2022 2 | 72 | 50 | 122 |
| 2022 1 | 125 | 59 | 184 |
| 2021 12 | 73 | 61 | 134 |
| 2021 11 | 87 | 46 | 133 |
| 2021 10 | 75 | 68 | 143 |
| 2021 9 | 87 | 71 | 158 |
| 2021 8 | 100 | 71 | 171 |
| 2021 7 | 84 | 47 | 131 |
| 2021 6 | 179 | 66 | 245 |
| 2021 5 | 278 | 80 | 358 |
| 2021 4 | 1404 | 240 | 1644 |
| 2021 3 | 767 | 122 | 889 |
| 2021 2 | 290 | 68 | 358 |
| 2021 1 | 378 | 53 | 431 |
| 2020 12 | 145 | 26 | 171 |
| 2020 11 | 125 | 35 | 160 |
Show all
